US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ensysce Biosciences Inc.

0.4614

+0.00240.52%

Post-market: 0.48190.0205+4.44%19:10 EST

Volume:264.14K

Turnover:112.10K

Market Cap:1.68M

PE:-0.08

High:0.4880

Open:0.4800

Low:0.3780

Close:0.4590

52wk High:6.40

52wk Low:0.3780

Shares:3.63M

Float Shares:3.12M

Volume Ratio:1.39

T/O Rate:8.47%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-6.0968

EPS(LYR):-11.4482

ROE:-294.39%

ROA:-109.79%

PB:1.39

PE(LYR):-0.04

Loading ...

Overview Company News Filings

Ensysce Biosciences Reaches Key Enrollment Milestone in Phase 3 Trial of PF614 for Acute Pain

Ensysce Biosciences expands global opioid patent portfolio

Ensysce Biosciences Inc. held annual shareholder meeting

Ensysce Biosciences Launches Phase 3 Trial of Abuse-Resistant Opioid PF614

Ensysce Biosciences Secures New U.S. Patent for MPAR® Overdose Protection Technology, Extending Coverage Through 2042

Ensysce Biosciences Inc. Announces Date for Upcoming Annual Stockholders Meeting

Ensysce Biosciences receives FDA feedback on PF614 manufacturing

Ensysce Biosciences secures $4M financing

Ensysce Biosciences posts $3.7 million net loss for Q3 2025

Ensysce Biosciences Q3 Net Income USD -3.7 Million

THOMSON REUTERS

Ensysce Biosciences releases symposium highlights from PAINWeek 2025

Ensysce Biosciences Unveils Upcoming Phase 3 Trial for PF614 at PAINWeek 2025, Highlighting Innovative TAAP™ and MPAR® Technologies for Safer Opioid Use

Ensysce Biosciences' Geoff Birkett to Chair the Fierce New Product Planning Summit 2025

Ensysce Biosciences Inc. Unveils Presentation on Next-Generation Opioids and Overdose Protection Innovations

Ensysce Biosciences Q2 EPS $(0.79) Beats $(1.18) Estimate, Sales $1.371M Beat $650.000K Estimate

Ensysce Biosciences Q2 EPS USD -0.79

THOMSON REUTERS

Ensysce Biosciences Inc expected to post a loss of $1.18 a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ENSC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"ENSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENSC\",,,,,undefined,":{"symbol":"ENSC","market":"US","secType":"STK","nameCN":"Ensysce Biosciences Inc.","latestPrice":0.4614,"timestamp":1770411600000,"preClose":0.459,"halted":0,"volume":264135,"hourTrading":{"tag":"盘后","latestPrice":0.4819,"preClose":0.4614,"latestTime":"19:10 EST","volume":512,"amount":246.6592,"timestamp":1770423059941,"change":0.0205,"changeRate":0.04443,"amplitude":0.057651},"delay":0,"changeRate":0.005228758169934548,"floatShares":3119300,"shares":3632307,"eps":-6.0968,"marketStatus":"Market Closed","change":0.0024,"latestTime":"02-06 16:00:00 EST","open":0.48,"high":0.488,"low":0.378,"amount":112100.09053155,"amplitude":0.239651,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-6.0968,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.459,"preHourTrading":{"tag":"盘前","latestPrice":0.4479,"preClose":0.459,"latestTime":"08:53 EST","volume":1876,"amount":846.7904183200001,"timestamp":1770386013501,"change":-0.0111,"changeRate":-0.024183,"amplitude":0.091939},"postHourTrading":{"tag":"盘后","latestPrice":0.4819,"preClose":0.4614,"latestTime":"19:10 EST","volume":512,"amount":246.6592,"timestamp":1770423059941,"change":0.0205,"changeRate":0.04443,"amplitude":0.057651},"volumeRatio":1.388723857388724,"impliedVol":3.1521,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ENSC\",,,,,undefined,":{"symbol":"ENSC","floatShares":3119300,"roa":"-109.79%","roe":"-294.39%","lyrEps":-11.448165,"volumeRatio":1.388723857388724,"shares":3632307,"dividePrice":0,"high":0.488,"amplitude":0.239651,"preClose":0.459,"low":0.378,"week52Low":0.378,"pbRate":"1.39","psRate":"0.37","week52High":6.4,"institutionHeld":0,"latestPrice":0.4614,"eps":-6.0968,"divideRate":0,"volume":264135,"delay":0,"ttmEps":-6.0968,"open":0.48,"prevYearClose":0.92,"prevWeekClose":0.7262,"prevMonthClose":0.7262,"prevQuarterClose":0.92,"fiveDayClose":0.7262,"twentyDayClose":1.06,"sixtyDayClose":2.03},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENSC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"ENSC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-13","symbol":"ENSC","fiscalQuarterEnding":"2025/06","expectedEps":-1.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.79},{"market":"US","date":"2025-05-13","symbol":"ENSC","fiscalQuarterEnding":"2025/03","expectedEps":-3.02,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-1.39},{"market":"US","date":"2025-03-10","symbol":"ENSC","fiscalQuarterEnding":"2024/12","expectedEps":-2.74,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741579200000,"reportTimeType":"post","actualEps":-2.9},{"market":"US","date":"2024-12-06","symbol":"ENSC","defaultRemindTime":1733495400000,"type":"split","dateTimestamp":1733461200000,"forFactor":15,"toFactor":1,"ratio":15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENSC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ENSC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ENSC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ENSC","date":"2026-02-06","current":-0.075679,"percent":0.923623,"low":-1151.871294,"twenty":-1.060629,"median":-0.437558,"eighty":-0.228917,"high":2051.953734,"avg":-8.829265,"sd":273.223331,"marketCap":1667228},"quantilePoints":[{"date":"2021-07-02","current":2051.953734,"twenty":2050.538593,"median":2050.538593,"eighty":2051.387678,"marketCap":353522901},{"date":"2021-07-09","current":1665.538105,"twenty":1670.376702,"median":2037.802329,"eighty":2050.538593,"marketCap":286948898},{"date":"2021-07-16","current":1373.799461,"twenty":1582.794518,"median":1666.827366,"eighty":2047.99134,"marketCap":236686414},{"date":"2021-07-23","current":986.303472,"twenty":1176.265418,"median":1592.804232,"eighty":1966.125264,"marketCap":169926280},{"date":"2021-07-30","current":796.099172,"twenty":905.447974,"median":1416.070215,"eighty":1677.156928,"marketCap":137156742},{"date":"2021-08-06","current":598.835663,"twenty":785.954194,"median":1130.038123,"eighty":1667.600922,"marketCap":103171001},{"date":"2021-08-13","current":462.160228,"twenty":607.289814,"median":986.310516,"eighty":1664.774414,"marketCap":79623737},{"date":"2021-08-20","current":-800.661067,"twenty":514.012352,"median":880.640679,"eighty":1647.936568,"marketCap":79073287},{"date":"2021-08-27","current":-761.364824,"twenty":-747.61113,"median":789.758561,"eighty":1590.301804,"marketCap":75192390},{"date":"2021-09-03","current":-825.221223,"twenty":-767.750462,"median":676.332041,"eighty":1555.901866,"marketCap":81498848},{"date":"2021-09-10","current":-859.605437,"twenty":-780.52174,"median":598.835663,"eighty":1458.340968,"marketCap":84894633},{"date":"2021-09-17","current":-724.524585,"twenty":-780.52174,"median":555.860395,"eighty":1373.799461,"marketCap":71554048},{"date":"2021-09-24","current":-1102.750982,"twenty":-800.661067,"median":488.931707,"eighty":1361.174599,"marketCap":108907687},{"date":"2021-10-01","current":-704.876458,"twenty":-815.397165,"median":-708.560485,"eighty":1130.038123,"marketCap":69613599},{"date":"2021-10-08","current":-582.075678,"twenty":-800.661067,"median":-611.547874,"eighty":1000.40781,"marketCap":57485794},{"date":"2021-10-15","current":-582.075678,"twenty":-788.380994,"median":-604.17982,"eighty":986.317559,"marketCap":57485794},{"date":"2021-10-22","current":-547.691464,"twenty":-781.01294,"median":-601.723805,"eighty":986.303472,"marketCap":54090009},{"date":"2021-10-29","current":-540.32342,"twenty":-780.52174,"median":-596.811776,"eighty":885.234099,"marketCap":53362341},{"date":"2021-11-05","current":-552.603493,"twenty":-778.556926,"median":-582.075678,"eighty":880.640679,"marketCap":54575121},{"date":"2021-11-12","current":-542.779435,"twenty":-776.100911,"median":-575.935642,"eighty":879.231656,"marketCap":53604897},{"date":"2021-11-19","current":-2.041392,"twenty":-776.100911,"median":-559.971547,"eighty":796.099172,"marketCap":38445141},{"date":"2021-11-26","current":-2.034952,"twenty":-774.1361,"median":-555.059508,"eighty":785.954194,"marketCap":38323863},{"date":"2021-12-03","current":-1.609931,"twenty":-769.715274,"median":-550.147479,"eighty":769.891308,"marketCap":30319512},{"date":"2021-12-10","current":-5.705594,"twenty":-764.803244,"median":-542.779435,"eighty":694.367562,"marketCap":107452350},{"date":"2021-12-17","current":-3.812316,"twenty":-763.820838,"median":-539.095413,"eighty":648.151541,"marketCap":71796604},{"date":"2021-12-23","current":-6.594276,"twenty":-762.34723,"median":-537.867406,"eighty":615.743964,"marketCap":124188721},{"date":"2021-12-31","current":-6.053339,"twenty":-758.417601,"median":-6.594276,"eighty":588.690681,"marketCap":114001365},{"date":"2022-01-07","current":-5.138899,"twenty":-754.979176,"median":-6.175695,"eighty":578.5457,"marketCap":96779882},{"date":"2022-01-14","current":-4.224458,"twenty":-753.99677,"median":-5.705594,"eighty":551.774222,"marketCap":79558399},{"date":"2022-01-21","current":-3.078187,"twenty":-753.99677,"median":-5.692715,"eighty":524.720941,"marketCap":57970907},{"date":"2022-01-28","current":-2.150867,"twenty":-750.067147,"median":-5.409367,"eighty":500.767517,"marketCap":40506868},{"date":"2022-02-04","current":-2.073591,"twenty":-736.313461,"median":-5.254814,"eighty":478.223115,"marketCap":39051531},{"date":"2022-02-11","current":-2.073591,"twenty":-719.612556,"median":-4.939267,"eighty":276.652164,"marketCap":39051531},{"date":"2022-02-18","current":-1.39742,"twenty":-709.29729,"median":-4.623721,"eighty":-1.482424,"marketCap":26317336},{"date":"2022-02-25","current":-1.40386,"twenty":-687.68435,"median":-4.456288,"eighty":-1.367797,"marketCap":26438614},{"date":"2022-03-04","current":-1.378101,"twenty":-617.442308,"median":-4.218019,"eighty":-1.378101,"marketCap":25953502},{"date":"2022-03-11","current":-1.416739,"twenty":-611.056671,"median":-4.17294,"eighty":-1.367797,"marketCap":26681170},{"date":"2022-03-18","current":-1.584172,"twenty":-608.600654,"median":-3.915351,"eighty":-1.367797,"marketCap":29834399},{"date":"2022-03-25","current":-1.455377,"twenty":-606.635834,"median":-3.72216,"eighty":-1.378101,"marketCap":27408838},{"date":"2022-04-01","current":-0.909052,"twenty":-605.653428,"median":-3.026669,"eighty":-1.367797,"marketCap":26438614},{"date":"2022-04-08","current":-0.942412,"twenty":-601.723805,"median":-2.640286,"eighty":-1.243923,"marketCap":27408838},{"date":"2022-04-14","current":-0.892372,"twenty":-601.723805,"median":-2.31186,"eighty":-1.109211,"marketCap":25953502},{"date":"2022-04-22","current":-0.884033,"twenty":-599.267791,"median":-2.221704,"eighty":-0.942412,"marketCap":25710946},{"date":"2022-04-29","current":-0.917392,"twenty":-599.267791,"median":-2.189506,"eighty":-0.917392,"marketCap":26681170},{"date":"2022-05-06","current":-0.935552,"twenty":-594.355761,"median":-2.131548,"eighty":-0.917392,"marketCap":27209326},{"date":"2022-05-13","current":-0.797005,"twenty":-582.075678,"median":-2.08647,"eighty":-0.892372,"marketCap":23214444},{"date":"2022-05-20","current":-0.624837,"twenty":-582.075678,"median":-2.073591,"eighty":-0.867353,"marketCap":18199682},{"date":"2022-05-27","current":-0.62899,"twenty":-582.075678,"median":-2.041392,"eighty":-0.82967,"marketCap":18320644},{"date":"2022-06-03","current":-0.645958,"twenty":-578.146055,"median":-2.034952,"eighty":-0.778733,"marketCap":18814863},{"date":"2022-06-10","current":-0.587461,"twenty":-575.198838,"median":-1.960895,"eighty":-0.698325,"marketCap":17111019},{"date":"2022-06-17","current":-0.537744,"twenty":-566.848388,"median":-1.931917,"eighty":-0.663661,"marketCap":15662924},{"date":"2022-06-24","current":-0.547118,"twenty":-561.936359,"median":-1.803122,"eighty":-0.641971,"marketCap":15935954},{"date":"2022-07-01","current":-0.675147,"twenty":-559.971547,"median":-1.758044,"eighty":-0.628942,"marketCap":19665057},{"date":"2022-07-08","current":-0.740288,"twenty":-558.006731,"median":-1.63569,"eighty":-0.63179,"marketCap":21562441},{"date":"2022-07-15","current":-0.73318,"twenty":-554.077102,"median":-1.584172,"eighty":-0.639978,"marketCap":21355409},{"date":"2022-07-22","current":-0.750097,"twenty":-552.603493,"median":-1.526215,"eighty":-0.650372,"marketCap":21848142},{"date":"2022-07-29","current":-0.645214,"twenty":-550.638681,"median":-1.455377,"eighty":-0.648267,"marketCap":18793198},{"date":"2022-08-05","current":-0.542837,"twenty":-547.691464,"median":-1.436058,"eighty":-0.628919,"marketCap":15811251},{"date":"2022-08-12","current":-0.502219,"twenty":-545.726652,"median":-1.416739,"eighty":-0.623627,"marketCap":18104172},{"date":"2022-08-19","current":-0.4432,"twenty":-541.797029,"median":-1.400842,"eighty":-0.597747,"marketCap":15976634},{"date":"2022-08-26","current":-0.437558,"twenty":-540.32342,"median":-1.39098,"eighty":-0.585573,"marketCap":15773232},{"date":"2022-09-02","current":-0.436493,"twenty":-539.341014,"median":-1.39098,"eighty":-0.574176,"marketCap":15734855},{"date":"2022-09-09","current":-0.364844,"twenty":-537.867406,"median":-1.38776,"eighty":-0.560252,"marketCap":13152036},{"date":"2022-09-16","current":-0.333012,"twenty":-537.867406,"median":-1.378101,"eighty":-0.543432,"marketCap":12004543},{"date":"2022-09-23","current":-0.234109,"twenty":-537.376203,"median":-1.352342,"eighty":-0.508327,"marketCap":8439255},{"date":"2022-09-30","current":-0.228893,"twenty":-429.647968,"median":-1.243734,"eighty":-0.498322,"marketCap":8251204},{"date":"2022-10-07","current":-0.234216,"twenty":-6.555638,"median":-1.18844,"eighty":-0.457146,"marketCap":8443092},{"date":"2022-10-14","current":-0.220376,"twenty":-6.367598,"median":-1.109211,"eighty":-0.440474,"marketCap":7944182},{"date":"2022-10-21","current":-0.210262,"twenty":-6.210469,"median":-1.003086,"eighty":-0.435641,"marketCap":7579594},{"date":"2022-10-28","current":-0.250893,"twenty":-6.104857,"median":-0.950752,"eighty":-0.392333,"marketCap":9044283},{"date":"2022-11-04","current":-0.17653,"twenty":-5.98379,"median":-0.934812,"eighty":-0.354113,"marketCap":6363632},{"date":"2022-11-11","current":-0.1248,"twenty":-5.705594,"median":-0.917392,"eighty":-0.266963,"marketCap":4498831},{"date":"2022-11-18","current":-0.202801,"twenty":-5.703018,"median":-0.904882,"eighty":-0.252442,"marketCap":5824224},{"date":"2022-11-25","current":-0.338332,"twenty":-5.692715,"median":-0.892372,"eighty":-0.252314,"marketCap":9716511},{"date":"2022-12-02","current":-0.220875,"twenty":-5.666956,"median":-0.884033,"eighty":-0.252314,"marketCap":6343293},{"date":"2022-12-09","current":-0.218547,"twenty":-5.525282,"median":-0.867353,"eighty":-0.245714,"marketCap":6276429},{"date":"2022-12-16","current":-0.173271,"twenty":-5.293452,"median":-0.82967,"eighty":-0.238048,"marketCap":4976162},{"date":"2022-12-23","current":-0.160808,"twenty":-5.254814,"median":-0.801912,"eighty":-0.234216,"marketCap":4618230},{"date":"2022-12-30","current":-0.167485,"twenty":-5.254814,"median":-0.794791,"eighty":-0.233587,"marketCap":4809988},{"date":"2023-01-06","current":-0.162144,"twenty":-5.208448,"median":-0.777262,"eighty":-0.229014,"marketCap":4656609},{"date":"2023-01-13","current":-0.172083,"twenty":-5.154354,"median":-0.761172,"eighty":-0.22176,"marketCap":4942034},{"date":"2023-01-20","current":-0.151312,"twenty":-4.979194,"median":-0.754483,"eighty":-0.220248,"marketCap":4345527},{"date":"2023-01-27","current":-0.15636,"twenty":-4.713877,"median":-0.749721,"eighty":-0.212142,"marketCap":4490485},{"date":"2023-02-03","current":-0.285115,"twenty":-4.654632,"median":-0.740288,"eighty":-0.212142,"marketCap":8188175},{"date":"2023-02-10","current":-0.319777,"twenty":-4.577355,"median":-0.716973,"eighty":-0.2146,"marketCap":9183632},{"date":"2023-02-17","current":-0.306121,"twenty":-4.487199,"median":-0.704416,"eighty":-0.217004,"marketCap":8791464},{"date":"2023-02-24","current":-0.268404,"twenty":-4.453712,"median":-0.69164,"eighty":-0.21887,"marketCap":7708271},{"date":"2023-03-03","current":-0.278653,"twenty":-4.399619,"median":-0.674554,"eighty":-0.220206,"marketCap":8002622},{"date":"2023-03-10","current":-0.295605,"twenty":-4.221882,"median":-0.670756,"eighty":-0.220476,"marketCap":8489450},{"date":"2023-03-17","current":-0.319044,"twenty":-4.206427,"median":-0.666784,"eighty":-0.220988,"marketCap":9162596},{"date":"2023-03-24","current":-0.28195,"twenty":-4.183244,"median":-0.656993,"eighty":-0.221547,"marketCap":8097283},{"date":"2023-03-31","current":-0.251749,"twenty":-4.160061,"median":-0.645586,"eighty":-0.223101,"marketCap":6085356},{"date":"2023-04-06","current":-0.180809,"twenty":-4.108543,"median":-0.632491,"eighty":-0.22144,"marketCap":4370577},{"date":"2023-04-14","current":-0.203676,"twenty":-3.992628,"median":-0.624837,"eighty":-0.218547,"marketCap":4923327},{"date":"2023-04-21","current":-0.218035,"twenty":-3.838075,"median":-0.616531,"eighty":-0.218035,"marketCap":5270402},{"date":"2023-04-28","current":-0.207399,"twenty":-3.812316,"median":-0.595341,"eighty":-0.211114,"marketCap":5013309},{"date":"2023-05-05","current":-0.186,"twenty":-3.72216,"median":-0.589774,"eighty":-0.207399,"marketCap":4496040},{"date":"2023-05-12","current":-0.170057,"twenty":-3.593365,"median":-0.578926,"eighty":-0.203676,"marketCap":4110665},{"date":"2023-05-19","current":-0.138524,"twenty":-3.078187,"median":-0.574237,"eighty":-0.198975,"marketCap":3519757},{"date":"2023-05-26","current":-0.119818,"twenty":-2.975152,"median":-0.564854,"eighty":-0.195168,"marketCap":3044461},{"date":"2023-06-02","current":-0.12184,"twenty":-2.799991,"median":-0.554475,"eighty":-0.191738,"marketCap":3095845},{"date":"2023-06-09","current":-0.11729,"twenty":-2.663469,"median":-0.544325,"eighty":-0.188162,"marketCap":2980232},{"date":"2023-06-16","current":-0.120324,"twenty":-2.403304,"median":-0.537744,"eighty":-0.185529,"marketCap":3057307},{"date":"2023-06-22","current":-0.110212,"twenty":-2.331179,"median":-0.512831,"eighty":-0.181667,"marketCap":2800390},{"date":"2023-06-30","current":-0.089484,"twenty":-2.31186,"median":-0.504284,"eighty":-0.180301,"marketCap":2273711},{"date":"2023-07-07","current":-0.108696,"twenty":-2.269358,"median":-0.500344,"eighty":-0.179074,"marketCap":2761853},{"date":"2023-07-14","current":-0.095551,"twenty":-2.235871,"median":-0.48602,"eighty":-0.176463,"marketCap":2427861},{"date":"2023-07-21","current":-0.228917,"twenty":-2.222992,"median":-0.463108,"eighty":-0.17453,"marketCap":5816563},{"date":"2023-07-28","current":-0.230007,"twenty":-2.204961,"median":-0.448416,"eighty":-0.176463,"marketCap":5844261},{"date":"2023-08-04","current":-0.212566,"twenty":-2.189506,"median":-0.439793,"eighty":-0.177048,"marketCap":5401094},{"date":"2023-08-11","current":-0.213656,"twenty":-2.17405,"median":-0.436546,"eighty":-0.178163,"marketCap":5428792},{"date":"2023-08-18","current":-0.284273,"twenty":-2.145715,"median":-0.431596,"eighty":-0.17894,"marketCap":5612832},{"date":"2023-08-25","current":-0.281373,"twenty":-2.132836,"median":-0.405938,"eighty":-0.179667,"marketCap":5555558},{"date":"2023-09-01","current":-0.268319,"twenty":-2.119956,"median":-0.373875,"eighty":-0.180213,"marketCap":5297826},{"date":"2023-09-08","current":-0.274121,"twenty":-2.107077,"median":-0.367186,"eighty":-0.180403,"marketCap":5412374},{"date":"2023-09-15","current":-0.255266,"twenty":-2.08647,"median":-0.356221,"eighty":-0.180828,"marketCap":5040094},{"date":"2023-09-22","current":-0.23061,"twenty":-2.083894,"median":-0.35054,"eighty":-0.181286,"marketCap":4553267},{"date":"2023-09-29","current":-0.197251,"twenty":-2.073591,"median":-0.336589,"eighty":-0.182977,"marketCap":3894618},{"date":"2023-10-06","current":-0.159541,"twenty":-2.068439,"median":-0.324381,"eighty":-0.181273,"marketCap":3150059},{"date":"2023-10-12","current":-0.175495,"twenty":-2.047832,"median":-0.319777,"eighty":-0.180154,"marketCap":3465064},{"date":"2023-10-20","current":-0.224808,"twenty":-2.041392,"median":-0.319097,"eighty":-0.180301,"marketCap":4438719},{"date":"2023-10-27","current":-0.15519,"twenty":-2.038816,"median":-0.31805,"eighty":-0.180213,"marketCap":3064148},{"date":"2023-11-03","current":-0.147166,"twenty":-2.034952,"median":-0.312913,"eighty":-0.177994,"marketCap":2905715},{"date":"2023-11-10","current":-0.135455,"twenty":-2.034952,"median":-0.311621,"eighty":-0.175524,"marketCap":2674479},{"date":"2023-11-17","current":-0.234708,"twenty":-2.022073,"median":-0.305807,"eighty":-0.175796,"marketCap":2957311},{"date":"2023-11-24","current":-0.219726,"twenty":-1.970555,"median":-0.300549,"eighty":-0.176418,"marketCap":2768546},{"date":"2023-12-01","current":-0.284645,"twenty":-1.951236,"median":-0.295186,"eighty":-0.17653,"marketCap":3586526},{"date":"2023-12-08","current":-0.245519,"twenty":-1.931917,"median":-0.292717,"eighty":-0.177824,"marketCap":3093536},{"date":"2023-12-15","current":-0.25718,"twenty":-1.931917,"median":-0.287495,"eighty":-0.178672,"marketCap":3240458},{"date":"2023-12-22","current":-0.26467,"twenty":-1.893278,"median":-0.287174,"eighty":-0.179342,"marketCap":3334840},{"date":"2023-12-29","current":-0.25718,"twenty":-1.839184,"median":-0.286889,"eighty":-0.179829,"marketCap":3240458},{"date":"2024-01-05","current":-0.287142,"twenty":-1.800546,"median":-0.286002,"eighty":-0.180183,"marketCap":3617987},{"date":"2024-01-12","current":-0.352061,"twenty":-1.787667,"median":-0.286889,"eighty":-0.180403,"marketCap":4435967},{"date":"2024-01-19","current":-0.29713,"twenty":-1.777363,"median":-0.287142,"eighty":-0.180809,"marketCap":3743830},{"date":"2024-01-26","current":-0.374533,"twenty":-1.738725,"median":-0.287142,"eighty":-0.180905,"marketCap":4719114},{"date":"2024-02-02","current":-0.36954,"twenty":-1.648569,"median":-0.287174,"eighty":-0.181297,"marketCap":4656192},{"date":"2024-02-09","current":-0.294633,"twenty":-1.62281,"median":-0.290994,"eighty":-0.182747,"marketCap":3712369},{"date":"2024-02-16","current":-0.476633,"twenty":-1.609931,"median":-0.289857,"eighty":-0.182811,"marketCap":6005566},{"date":"2024-02-23","current":-0.47931,"twenty":-1.589324,"median":-0.293303,"eighty":-0.183477,"marketCap":6039299},{"date":"2024-03-01","current":-0.49934,"twenty":-1.563565,"median":-0.295134,"eighty":-0.185529,"marketCap":6291674},{"date":"2024-03-08","current":-0.420937,"twenty":-1.537806,"median":-0.29713,"eighty":-0.187269,"marketCap":5303792},{"date":"2024-03-15","current":-0.401657,"twenty":-1.522351,"median":-0.301226,"eighty":-0.187592,"marketCap":5060871},{"date":"2024-03-22","current":-0.539343,"twenty":-1.509471,"median":-0.306121,"eighty":-0.187752,"marketCap":5724083},{"date":"2024-03-28","current":-0.552464,"twenty":-1.475984,"median":-0.311621,"eighty":-0.188069,"marketCap":5863337},{"date":"2024-04-05","current":-0.582158,"twenty":-1.455377,"median":-0.312913,"eighty":-0.188946,"marketCap":6178491},{"date":"2024-04-12","current":-0.520524,"twenty":-1.44765,"median":-0.317056,"eighty":-0.189992,"marketCap":5524363},{"date":"2024-04-19","current":-0.400674,"twenty":-1.43477,"median":-0.319149,"eighty":-0.190623,"marketCap":4252385},{"date":"2024-04-26","current":-0.390727,"twenty":-1.426836,"median":-0.324381,"eighty":-0.191499,"marketCap":4146813},{"date":"2024-05-03","current":-0.406665,"twenty":-1.420036,"median":-0.328965,"eighty":-0.192296,"marketCap":4315962},{"date":"2024-05-10","current":-0.38701,"twenty":-1.416739,"median":-0.333012,"eighty":-0.192744,"marketCap":4107370},{"date":"2024-05-17","current":-0.414034,"twenty":-1.409012,"median":-0.340203,"eighty":-0.194261,"marketCap":4778658},{"date":"2024-05-24","current":-0.386958,"twenty":-1.400239,"median":-0.345309,"eighty":-0.195168,"marketCap":4466149},{"date":"2024-05-31","current":-0.38446,"twenty":-1.397663,"median":-0.35054,"eighty":-0.195327,"marketCap":4437325},{"date":"2024-06-07","current":-0.35929,"twenty":-1.394844,"median":-0.352061,"eighty":-0.195908,"marketCap":4146813},{"date":"2024-06-14","current":-0.348315,"twenty":-1.39098,"median":-0.352127,"eighty":-0.196588,"marketCap":4020141},{"date":"2024-06-21","current":-0.358489,"twenty":-1.39098,"median":-0.352127,"eighty":-0.197251,"marketCap":4137567},{"date":"2024-06-28","current":-0.352192,"twenty":-1.39098,"median":-0.352192,"eighty":-0.197427,"marketCap":4064893},{"date":"2024-07-05","current":-0.295739,"twenty":-1.39098,"median":-0.352061,"eighty":-0.197948,"marketCap":3413327},{"date":"2024-07-12","current":-0.308291,"twenty":-1.39098,"median":-0.35054,"eighty":-0.199037,"marketCap":3558204},{"date":"2024-07-15","current":-0.302639,"twenty":-1.39098,"median":-0.349428,"eighty":-0.199099,"marketCap":3492971},{"date":"2024-08-02","current":-0.303954,"twenty":-1.39098,"median":-0.348315,"eighty":-0.199161,"marketCap":3508142},{"date":"2024-08-09","current":-0.241717,"twenty":-1.387116,"median":-0.345859,"eighty":-0.199565,"marketCap":2789826},{"date":"2024-08-16","current":-0.26447,"twenty":-1.380677,"median":-0.342074,"eighty":-0.199992,"marketCap":2982489},{"date":"2024-08-23","current":-0.307981,"twenty":-1.378101,"median":-0.336589,"eighty":-0.20065,"marketCap":3473180},{"date":"2024-08-30","current":-0.307305,"twenty":-1.370373,"median":-0.334845,"eighty":-0.202073,"marketCap":3465556},{"date":"2024-09-06","current":-0.364516,"twenty":-1.360069,"median":-0.341743,"eighty":-0.202979,"marketCap":4110738},{"date":"2024-09-13","current":-0.306193,"twenty":-1.352342,"median":-0.340037,"eighty":-0.203419,"marketCap":3453020},{"date":"2024-09-20","current":-0.321066,"twenty":-1.320968,"median":-0.335355,"eighty":-0.203676,"marketCap":3620738},{"date":"2024-09-27","current":-0.26527,"twenty":-1.261837,"median":-0.332941,"eighty":-0.20384,"marketCap":2991521},{"date":"2024-10-04","current":-0.225611,"twenty":-1.240811,"median":-0.332086,"eighty":-0.204208,"marketCap":2544273},{"date":"2024-10-11","current":-0.228772,"twenty":-1.222236,"median":-0.329966,"eighty":-0.204208,"marketCap":2579914},{"date":"2024-10-18","current":-0.220531,"twenty":-1.190942,"median":-0.325844,"eighty":-0.204432,"marketCap":2486982},{"date":"2024-10-25","current":-0.387436,"twenty":-1.154623,"median":-0.327156,"eighty":-0.205107,"marketCap":4369210},{"date":"2024-10-31","current":-0.78508,"twenty":-1.119973,"median":-0.329966,"eighty":-0.206243,"marketCap":8853546},{"date":"2024-11-08","current":-0.85568,"twenty":-1.097263,"median":-0.332086,"eighty":-0.207117,"marketCap":9649713},{"date":"2024-11-15","current":-1.112489,"twenty":-1.111833,"median":-0.332941,"eighty":-0.207179,"marketCap":8817483},{"date":"2024-11-22","current":-1.463005,"twenty":-1.187197,"median":-0.335355,"eighty":-0.2074,"marketCap":11595645},{"date":"2024-11-29","current":-1.219747,"twenty":-1.20095,"median":-0.339535,"eighty":-0.207404,"marketCap":9667605},{"date":"2024-12-06","current":-1.19258,"twenty":-1.236427,"median":-0.343222,"eighty":-0.208116,"marketCap":9452284},{"date":"2024-12-13","current":-1.007606,"twenty":-1.236427,"median":-0.346409,"eighty":-0.208205,"marketCap":7986196},{"date":"2024-12-20","current":-1.3089,"twenty":-1.236427,"median":-0.348396,"eighty":-0.208854,"marketCap":10374225},{"date":"2024-12-27","current":-1.541045,"twenty":-1.25409,"median":-0.351152,"eighty":-0.20886,"marketCap":12214182},{"date":"2025-01-03","current":-1.358293,"twenty":-1.336231,"median":-0.352061,"eighty":-0.209,"marketCap":10765705},{"date":"2025-01-10","current":-1.303961,"twenty":-1.349402,"median":-0.352192,"eighty":-0.209431,"marketCap":10335077},{"date":"2025-01-17","current":-1.152491,"twenty":-1.345121,"median":-0.352708,"eighty":-0.209959,"marketCap":9134538},{"date":"2025-01-24","current":-1.307254,"twenty":-1.346768,"median":-0.358489,"eighty":-0.210043,"marketCap":10361175},{"date":"2025-01-31","current":-1.104745,"twenty":-1.338865,"median":-0.359421,"eighty":-0.21027,"marketCap":8756107},{"date":"2025-02-07","current":-1.053706,"twenty":-1.330304,"median":-0.362904,"eighty":-0.210466,"marketCap":8351577},{"date":"2025-02-14","current":-0.996081,"twenty":-1.315486,"median":-0.36403,"eighty":-0.21134,"marketCap":7894850},{"date":"2025-02-21","current":-0.926932,"twenty":-1.3089,"median":-0.364942,"eighty":-0.212244,"marketCap":7346778},{"date":"2025-02-28","current":-0.864368,"twenty":-1.307254,"median":-0.367373,"eighty":-0.212536,"marketCap":6850903},{"date":"2025-03-07","current":-0.856136,"twenty":-1.303961,"median":-0.371707,"eighty":-0.212566,"marketCap":6785656},{"date":"2025-03-14","current":-0.637359,"twenty":-1.279265,"median":-0.374533,"eighty":-0.212566,"marketCap":5090547},{"date":"2025-03-21","current":-0.626307,"twenty":-1.273906,"median":-0.375127,"eighty":-0.213521,"marketCap":5002277},{"date":"2025-03-28","current":-0.548899,"twenty":-1.249136,"median":-0.377888,"eighty":-0.213656,"marketCap":4384018},{"date":"2025-04-04","current":-0.402877,"twenty":-1.247983,"median":-0.38361,"eighty":-0.213683,"marketCap":3217756},{"date":"2025-04-11","current":-0.330747,"twenty":-1.243734,"median":-0.377888,"eighty":-0.213752,"marketCap":2641651},{"date":"2025-04-17","current":-0.330747,"twenty":-1.241359,"median":-0.377888,"eighty":-0.214536,"marketCap":2641651},{"date":"2025-04-25","current":-0.582325,"twenty":-1.237295,"median":-0.37685,"eighty":-0.214732,"marketCap":4650993},{"date":"2025-05-02","current":-0.522509,"twenty":-1.233817,"median":-0.383262,"eighty":-0.215726,"marketCap":4173247},{"date":"2025-05-09","current":-0.365932,"twenty":-1.222431,"median":-0.382514,"eighty":-0.21608,"marketCap":2922678},{"date":"2025-05-16","current":-0.441183,"twenty":-1.219747,"median":-0.383262,"eighty":-0.217023,"marketCap":3006986},{"date":"2025-05-23","current":-0.447368,"twenty":-1.206773,"median":-0.38446,"eighty":-0.217878,"marketCap":3049140},{"date":"2025-05-30","current":-0.451491,"twenty":-1.201982,"median":-0.384903,"eighty":-0.218264,"marketCap":3077243},{"date":"2025-06-06","current":-0.564674,"twenty":-1.195928,"median":-0.386958,"eighty":-0.218495,"marketCap":3848663},{"date":"2025-06-13","current":-0.516411,"twenty":-1.19104,"median":-0.388248,"eighty":-0.21863,"marketCap":3519717},{"date":"2025-06-20","current":-0.513998,"twenty":-1.188835,"median":-0.39137,"eighty":-0.218686,"marketCap":3503270},{"date":"2025-06-27","current":-0.535716,"twenty":-1.185222,"median":-0.394081,"eighty":-0.219102,"marketCap":3651296},{"date":"2025-07-03","current":-0.557434,"twenty":-1.182061,"median":-0.399017,"eighty":-0.219726,"marketCap":3799321},{"date":"2025-07-11","current":-0.504345,"twenty":-1.180151,"median":-0.399987,"eighty":-0.219813,"marketCap":3437481},{"date":"2025-07-18","current":-0.751307,"twenty":-1.178504,"median":-0.401019,"eighty":-0.22017,"marketCap":5120707},{"date":"2025-07-25","current":-0.76522,"twenty":-1.176936,"median":-0.401964,"eighty":-0.220207,"marketCap":5215535},{"date":"2025-08-01","current":-0.726959,"twenty":-1.175387,"median":-0.402877,"eighty":-0.220276,"marketCap":4954758},{"date":"2025-08-08","current":-0.723481,"twenty":-1.169069,"median":-0.405593,"eighty":-0.220392,"marketCap":4931051},{"date":"2025-08-15","current":-0.929108,"twenty":-1.150186,"median":-0.408094,"eighty":-0.220472,"marketCap":6114994},{"date":"2025-08-22","current":-0.933618,"twenty":-1.139069,"median":-0.409736,"eighty":-0.220573,"marketCap":6144679},{"date":"2025-08-29","current":-0.947149,"twenty":-1.130745,"median":-0.414034,"eighty":-0.220768,"marketCap":6233732},{"date":"2025-09-05","current":-0.9697,"twenty":-1.127795,"median":-0.418503,"eighty":-0.220875,"marketCap":6382154},{"date":"2025-09-12","current":-0.960724,"twenty":-1.122663,"median":-0.421877,"eighty":-0.221392,"marketCap":6323082},{"date":"2025-09-19","current":-0.947149,"twenty":-1.117916,"median":-0.425864,"eighty":-0.22144,"marketCap":6233732},{"date":"2025-09-26","current":-1.019312,"twenty":-1.112489,"median":-0.430234,"eighty":-0.221723,"marketCap":6708683},{"date":"2025-10-03","current":-1.105007,"twenty":-1.11133,"median":-0.434538,"eighty":-0.221973,"marketCap":7272687},{"date":"2025-10-10","current":-1.050884,"twenty":-1.11133,"median":-0.435042,"eighty":-0.224695,"marketCap":6916474},{"date":"2025-10-17","current":-1.15913,"twenty":-1.114027,"median":-0.436493,"eighty":-0.224808,"marketCap":7628901},{"date":"2025-10-24","current":-0.951659,"twenty":-1.114027,"median":-0.438675,"eighty":-0.225611,"marketCap":6263416},{"date":"2025-10-31","current":-0.97421,"twenty":-1.112489,"median":-0.441183,"eighty":-0.225647,"marketCap":6411839},{"date":"2025-11-07","current":-0.933618,"twenty":-1.11133,"median":-0.4464,"eighty":-0.225968,"marketCap":6144679},{"date":"2025-11-14","current":-0.933618,"twenty":-1.109517,"median":-0.447368,"eighty":-0.226737,"marketCap":6144679},{"date":"2025-11-21","current":-0.519612,"twenty":-1.109211,"median":-0.450935,"eighty":-0.227075,"marketCap":5701431},{"date":"2025-11-28","current":-0.571251,"twenty":-1.10856,"median":-0.452846,"eighty":-0.227389,"marketCap":6268033},{"date":"2025-12-05","current":-0.526067,"twenty":-1.105685,"median":-0.460769,"eighty":-0.227585,"marketCap":5772257},{"date":"2025-12-12","current":-0.470074,"twenty":-1.104797,"median":-0.465167,"eighty":-0.227723,"marketCap":5157875},{"date":"2025-12-19","current":-0.377383,"twenty":-1.097738,"median":-0.463108,"eighty":-0.228568,"marketCap":4140829},{"date":"2025-12-26","current":-0.367452,"twenty":-1.095986,"median":-0.455656,"eighty":-0.228845,"marketCap":4031860},{"date":"2026-01-02","current":-0.304555,"twenty":-1.094182,"median":-0.452138,"eighty":-0.228893,"marketCap":3341722},{"date":"2026-01-09","current":-0.3509,"twenty":-1.089539,"median":-0.450036,"eighty":-0.228903,"marketCap":3850245},{"date":"2026-01-16","current":-0.297934,"twenty":-1.081354,"median":-0.447139,"eighty":-0.228917,"marketCap":3269076},{"date":"2026-01-23","current":-0.294194,"twenty":-1.072533,"median":-0.445907,"eighty":-0.228952,"marketCap":3228031},{"date":"2026-01-30","current":-0.238347,"twenty":-1.067528,"median":-0.440503,"eighty":-0.229277,"marketCap":2615261},{"date":"2026-02-06","current":-0.151946,"twenty":-1.060629,"median":-0.437558,"eighty":-0.228917,"marketCap":1667228}],"updateTime":1770488319238},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ENSC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606190807","title":"Ensysce Biosciences Reaches Key Enrollment Milestone in Phase 3 Trial of PF614 for Acute Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2606190807","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606190807?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:02","pubTimestamp":1769605340,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc. has announced that enrollment has reached 50% of the targeted subjects for interim review in its pivotal Phase 3 clinical trial of PF614, a next-generation opioid candidate for severe acute pain. The PF614-301 trial is a multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of PF614 for the treatment of moderate to severe pain following abdominoplasty. Enrollment began in late December 2025 and is ongoing at three U.S. clinical sites. Interim results from the study have not yet been presented and will be available in the future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the original content used to generate this news brief via ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDL2Gcjpy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2605107106","title":"Ensysce Biosciences expands global opioid patent portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2605107106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605107106?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:15","pubTimestamp":1769001340,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (ENSC) received a Notice of Allowance from the Brazilian Patent Office for the issuance of a patent covering additional opioid ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-expands-global-opioid-patent-portfolio-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-expands-global-opioid-patent-portfolio-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2602942315","title":"Ensysce Biosciences Inc. held annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2602942315","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602942315?lang=en_us&edition=fundamental","pubTime":"2026-01-09 06:15","pubTimestamp":1767910524,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc. held its annual meeting of stockholders on January 7, 2026. Stockholders approved the issuance of shares of common stock and the exercise of warrants for common stock to an investor. An amendment to increase the number of shares available under the company's Omnibus Incentive Plan was also approved. The election of two Class I Directors, William Chang and Lee Rauch, was confirmed. Additionally, the appointment of Baker Tilly US, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified. One proposal relating to the adjournment of the meeting was not submitted to a vote.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDLb69ptZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2590434980","title":"Ensysce Biosciences Launches Phase 3 Trial of Abuse-Resistant Opioid PF614","url":"https://stock-news.laohu8.com/highlight/detail?id=2590434980","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590434980?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:00","pubTimestamp":1765285259,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc. has announced the initiation of enrollment in a pivotal Phase 3 clinical trial for PF614, its lead product candidate designed for pain management with built-in abuse protection. The company confirmed that the first patient has been enrolled in this trial. Results from the study have not yet been presented and will be available in the future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the original content used to generate this news brief via ACCESS Newswire  on December 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL6LXgWl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2588205343","title":"Ensysce Biosciences Secures New U.S. Patent for MPAR® Overdose Protection Technology, Extending Coverage Through 2042","url":"https://stock-news.laohu8.com/highlight/detail?id=2588205343","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588205343?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:01","pubTimestamp":1764680481,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc. announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a new patent covering its MPAR  technology. The patent, titled \"Compositions Comprising Enzyme-Cleavable Prodrugs and Controlled Release Nafamostat and Methods of Use Thereof,\" includes composition-of-matter and method-of-use claims, extending protection for MPAR through 2042. The technology is designed to provide overdose protection, with clinical trials demonstrating its ability to moderate opioid release when taken in excess.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the original content used to generate this news brief via ACCESS Newswire  on December 02, 2025, and is solely respo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL38rTCN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2585312388","title":"Ensysce Biosciences Inc. Announces Date for Upcoming Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2585312388","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585312388?lang=en_us&edition=fundamental","pubTime":"2025-11-22 03:22","pubTimestamp":1763752960,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc. has announced that it will hold its Annual Meeting of Stockholders virtually on December 23, 2025. The meeting will address several proposals as outlined in the proxy statement provided to shareholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 21, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nNDL5hLTpR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2584132566","title":"Ensysce Biosciences receives FDA feedback on PF614 manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584132566","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584132566?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:36","pubTimestamp":1763645782,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (ENSC) announced that the Food and Drug Administration provided Written Responses to a meeting request. Ensysce had requested g...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-receives-fda-feedback-on-pf614-manufacturing-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-receives-fda-feedback-on-pf614-manufacturing-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2584626269","title":"Ensysce Biosciences secures $4M financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584626269","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584626269?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:30","pubTimestamp":1763386226,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (ENSC) announced the closing of a $4 million convertible preferred stock financing, with upside to potentially $16 million of a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-secures-4m-financing-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-secures-4m-financing-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2583319684","title":"Ensysce Biosciences posts $3.7 million net loss for Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2583319684","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583319684?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:15","pubTimestamp":1763154923,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc. reported a net loss attributable to common stockholders of $3.7 million for the third quarter of 2025, compared to a gain of $0.7 million in the same period of 2024. Cash and cash equivalents were $1.7 million as of September 30, 2025, down from $3.5 million at the end of 2024. Other income for the third quarter of 2025 was $12.0 thousand, compared to $17.0 thousand in the third quarter of 2024. Federal grants provided $0.5 million in funding for the quarter, a decrease from $3.4 million in the prior year period. During the quarter, Ensysce initiated its pivotal Phase 3 study of PF614 and completed a convertible preferred stock offering in November 2025, raising $4.0 million with up to $16.0 million in additional funding possible over the next 24 months.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL7jdrf5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2583868439","title":"Ensysce Biosciences Q3 Net Income USD -3.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583868439","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583868439?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:15","pubTimestamp":1763154901,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nPLX4EF251:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2574817620","title":"Ensysce Biosciences releases symposium highlights from PAINWeek 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2574817620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574817620?lang=en_us&edition=fundamental","pubTime":"2025-10-10 20:20","pubTimestamp":1760098820,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (ENSC) released video highlights from its widely attended symposium at PAINWeek2025. The event, titled “Pain Management, RE-Inv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-releases-symposium-highlights-from-painweek-2025-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ensysce-biosciences-releases-symposium-highlights-from-painweek-2025-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2564875374","title":"Ensysce Biosciences Unveils Upcoming Phase 3 Trial for PF614 at PAINWeek 2025, Highlighting Innovative TAAP™ and MPAR® Technologies for Safer Opioid Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2564875374","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564875374?lang=en_us&edition=fundamental","pubTime":"2025-09-04 20:00","pubTimestamp":1756987231,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Unveils Upcoming Phase 3 Trial for PF614 at PAINWeek 2025, Highlighting Innovative TAAP and MPAR Technologies for Safer Opioid Use. Ensysce Biosciences Inc. , a clinical-stage company focused on developing innovative solutions for severe pain relief, announced its upcoming Phase 3 clinical trial for PF614, a novel treatment for acute post-surgical pain. The trial will explore the efficacy and safety of Ensysce's Trypsin Activated Abuse Protection  and Multi-Pill Abuse Resistance  technologies, designed to provide effective analgesia while reducing the risk of opioid abuse and overdose. The trial results are anticipated to be presented in the future, with the aim of establishing PF614 as a safer opioid option in pain management.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should no","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nNDLbXf1Bl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2560196923","title":"Ensysce Biosciences' Geoff Birkett to Chair the Fierce New Product Planning Summit 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2560196923","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560196923?lang=en_us&edition=fundamental","pubTime":"2025-08-19 20:00","pubTimestamp":1755604855,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc., a clinical-stage company focusing on novel solutions for severe pain, will participate in the Fierce New Product Planning Summit 2025 from September 8-11 in Philadelphia. Geoff Birkett, Ensysce's Chief Commercial Officer, will chair the event, deliver the Opening Remarks, and present a case study on launching successful brands.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ensysce Biosciences Inc. published the original content used to generate this news brief via ACCESS Newswire  on August 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250819:nNDL12KR9J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2559109964","title":"Ensysce Biosciences Inc. Unveils Presentation on Next-Generation Opioids and Overdose Protection Innovations","url":"https://stock-news.laohu8.com/highlight/detail?id=2559109964","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559109964?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:35","pubTimestamp":1755203717,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc. recently released an investor presentation highlighting its advancements in the development of 'next generation opioids' aimed at transforming analgesia through innovative trypsin-controlled chemistry. The company focuses on creating products with significant market potential, backed by FAST TRACK and BREAKTHROUGH THERAPY designations. Their lead product, nearing launch, has demonstrated both safety and efficacy. Ensysce emphasizes reducing clinical risks and shortening development timelines, supported by a robust global patent estate and an experienced management team. Their proprietary technologies, TAAP and MPAR, are designed to enhance abuse protection and provide overdose safety measures. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informatio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDL4gdKg1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2559981888","title":"Ensysce Biosciences Q2 EPS $(0.79) Beats $(1.18) Estimate, Sales $1.371M Beat $650.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2559981888","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559981888?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:20","pubTimestamp":1755116452,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences (NASDAQ:ENSC) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(1.18) by 33.05 percent. This is a 76.06 percent increase over losses of $(3.30) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47106737/ensysce-biosciences-q2-eps-0-79-beats-1-18-estimate-sales-1-371m-beat-650-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Ensysce Biosciences Q2 EPS $(0.79) Beats $(1.18) Estimate, Sales $1.371M Beat $650.000K Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC"],"gpt_icon":0},{"id":"2559989792","title":"Ensysce Biosciences Q2 EPS USD -0.79","url":"https://stock-news.laohu8.com/highlight/detail?id=2559989792","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559989792?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:15","pubTimestamp":1755116101,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nPLXA4780D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2557522029","title":"Ensysce Biosciences Inc  expected to post a loss of $1.18 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2557522029","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557522029?lang=en_us&edition=fundamental","pubTime":"2025-08-08 21:13","pubTimestamp":1754658822,"startTime":"0","endTime":"0","summary":"Ensysce Biosciences Inc  expected to post a loss of $1.18 a share - Earnings Preview Ensysce Biosciences Inc ENSC.OQ ENSC.O is expected to  show a rise in quarterly revenue when it reports  results on","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U022D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENSC"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}]}}